LT2662380T - Ibandronato polimorfo a medicininis panaudojimas - Google Patents

Ibandronato polimorfo a medicininis panaudojimas

Info

Publication number: LT2662380T
Authority: LT; Lithuania
Prior art keywords: medical use; ibandronate polymorph; ibandronate; polymorph; medical
Prior art date: 2005-02-01

Application number

LTEP13161008.1T

Other languages

English (en)

Inventor

Tim Sattelkau

Bernd Junghans

Uwe Eiermann

Bernhard Knipp

Original Assignee

Atnahs Pharma Uk Limited

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-02-01

Filing date

2006-01-24

Publication date

2019-03-12

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36090730&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LT2662380(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2006-01-24 Application filed by Atnahs Pharma Uk Limited filed Critical Atnahs Pharma Uk Limited

2019-03-12 Publication of LT2662380T publication Critical patent/LT2662380T/lt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
- C07F9/3839—Polyphosphonic acids
- C07F9/3873—Polyphosphonic acids containing nitrogen substituent, e.g. N.....H or N-hydrocarbon group which can be substituted by halogen or nitro(so), N.....O, N.....S, N.....C(=X)- (X =O, S), N.....N, N...C(=X)...N (X =O, S)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Physical Education & Sports Medicine (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Hematology (AREA)
Endocrinology (AREA)
Diabetes (AREA)
Obesity (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

LTEP13161008.1T 2005-02-01 2006-01-24 Ibandronato polimorfo a medicininis panaudojimas LT2662380T (lt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP05100686		2005-02-01

Publications (1)

Publication Number	Publication Date
LT2662380T true LT2662380T (lt)	2019-03-12

Family

ID=36090730

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
LTEP13161008.1T LT2662380T (lt)	2005-02-01	2006-01-24	Ibandronato polimorfo a medicininis panaudojimas

Country Status (25)

Country	Link
US (1)	US7714158B2 (lt)
EP (2)	EP2662380B1 (lt)
JP (2)	JP5828608B2 (lt)
KR (1)	KR100908529B1 (lt)
CN (1)	CN101111504B (lt)
AR (1)	AR053012A1 (lt)
AU (1)	AU2006210009B2 (lt)
BR (1)	BRPI0607092A2 (lt)
CA (1)	CA2594802C (lt)
CY (1)	CY1121703T1 (lt)
DK (1)	DK2662380T3 (lt)
ES (2)	ES2478302T3 (lt)
HU (1)	HUE042316T2 (lt)
IL (1)	IL184562A (lt)
LT (1)	LT2662380T (lt)
MX (1)	MX2007009107A (lt)
NO (1)	NO20073723L (lt)
PL (1)	PL2662380T3 (lt)
PT (1)	PT2662380T (lt)
RU (1)	RU2368617C2 (lt)
SI (1)	SI2662380T1 (lt)
TR (1)	TR201902609T4 (lt)
TW (1)	TWI374889B (lt)
WO (1)	WO2006081963A1 (lt)
ZA (1)	ZA200706168B (lt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR20070043043A (ko)	2004-08-23	2007-04-24	테바 파마슈티컬 인더스트리즈 리미티드	고체 및 결정 이반드로네이트 나트륨 및 이들의 제조 방법
EP1848727B1 (en) *	2005-02-01	2015-06-17	F.Hoffmann-La Roche Ag	Ibandronate polymorph b
WO2007074475A2 (en) *	2005-12-27	2007-07-05	Natco Pharma Limited	Novel polymorphic forms of ibandronate
CA2656053A1 (en) *	2006-07-03	2008-01-10	Generics [Uk] Limited	Novel process for the preparation of bisphosphonic acids
WO2008060609A1 (en) *	2006-11-16	2008-05-22	Teva Pharmaceutical Industries Ltd.	Crystalline forms of ibandronate sodium
CA2570949A1 (en) *	2006-12-12	2008-06-12	Apotex Pharmachem Inc.	Ibandronate sodium propylene glycol solvate and processes for the preparation thereof
CN101679465B (zh) *	2007-04-11	2013-08-21	霍夫曼-拉罗奇有限公司	伊班膦酸盐的制备方法
BRPI0810408A2 (pt)	2007-04-19	2014-11-04	Reddys Lab Ltd Dr	Polimorfos de ibandronaro de sódio
US20090042839A1 (en) *	2007-08-09	2009-02-12	Sharon Avhar-Maydan	Crystalline forms of ibandronate sodium
EP2128166A1 (en)	2008-05-20	2009-12-02	Chemo Ibérica, S.A.	Polymorphic forms of Ibandronate sodium and processes for preparation thereof
EP2180003A1 (en)	2008-10-21	2010-04-28	Zentiva, k.s.	Preparation of ibandronate trisodium
EP2609101B1 (en)	2010-07-14	2015-01-28	Pharmathen S.A.	Process for the preparation of 3-(n-methyl-n-pentyl)amino-1-hydroxypropane-1,1-diphosphonic acid salt or derivatives thereof
TR201200588A2 (tr)	2012-01-18	2012-07-23	Koçak Farma İlaç Ve Ki̇mya Sanayi̇ Anoni̇m Şi̇rketi̇	Sodyum ibandronat monohidrat polimorflarini ve polimorflu karışımlarını hazırlamak için prosesler.
KR20200085441A (ko)	2019-01-07	2020-07-15	엠에프씨 주식회사	이반드로네이트의 신규한 결정형 및 이의 제조방법

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3623397A1 (de) *	1986-07-11	1988-01-14	Boehringer Mannheim Gmbh	Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
TW198039B (lt) *	1988-11-28	1993-01-11	Ciba Geigy Ag
RU2172742C2 (ru) *	1995-12-28	2001-08-27	Пфайзер Инк.	Стимуляторы секреции гормона роста
IT1303672B1 (it) *	1998-07-28	2001-02-23	Nicox Sa	Sali nitrati di farmaci attivi nei disordini ossei
EP0998932A1 (de)	1998-10-09	2000-05-10	Boehringer Mannheim Gmbh	Feste pharmazeutische Darreichungsform enthaltend Diphosphonsäure oder deren Salze und Verfahren zu ihrer Herstellung
TW577893B (en) *	1998-10-16	2004-03-01	Akzo Nobel Nv	High purity composition comprising (7alpha, 17alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one
JP3793023B2 (ja)	1998-12-04	2006-07-05	ロシュダイアグノスティックスゲーエムベーハー	体内プロテーゼの骨統合を促進するためのイバンドロネートの使用
US6677320B2 (en) *	2000-01-20	2004-01-13	Hoffmann-La Roches Inc.	Parenteral bisphosphonate composition with improved local tolerance
CN1404836A (zh) *	2001-09-14	2003-03-26	中生北方生物工程开发研究所	埃本膦酸钠作为预防和治疗骨质疏松症的药物的有效成分的应用
KR20140021045A (ko)	2002-05-10	2014-02-19	에프. 호프만-라 로슈 아게	골다공증 치료 및 예방용 비스포스폰산
ES2530791T3 (es)	2002-12-20	2015-03-05	Hoffmann La Roche	Formulación de ibandronato de altas dosis
MX2007000087A (es) *	2004-06-23	2007-11-06	Teva Pharma	Acido ibandronico solido y cristalino.
KR20070043043A (ko) *	2004-08-23	2007-04-24	테바 파마슈티컬 인더스트리즈 리미티드	고체 및 결정 이반드로네이트 나트륨 및 이들의 제조 방법

2006
- 2006-01-24 CN CN2006800036914A patent/CN101111504B/zh not_active Expired - Fee Related
- 2006-01-24 HU HUE13161008A patent/HUE042316T2/hu unknown
- 2006-01-24 MX MX2007009107A patent/MX2007009107A/es active IP Right Grant
- 2006-01-24 ES ES06706375.0T patent/ES2478302T3/es active Active
- 2006-01-24 DK DK13161008.1T patent/DK2662380T3/en active
- 2006-01-24 PL PL13161008T patent/PL2662380T3/pl unknown
- 2006-01-24 KR KR1020077019795A patent/KR100908529B1/ko not_active Expired - Fee Related
- 2006-01-24 AU AU2006210009A patent/AU2006210009B2/en not_active Ceased
- 2006-01-24 CA CA2594802A patent/CA2594802C/en not_active Expired - Fee Related
- 2006-01-24 BR BRPI0607092-2A patent/BRPI0607092A2/pt active Search and Examination
- 2006-01-24 PT PT13161008T patent/PT2662380T/pt unknown
- 2006-01-24 TR TR2019/02609T patent/TR201902609T4/tr unknown
- 2006-01-24 EP EP13161008.1A patent/EP2662380B1/en not_active Not-in-force
- 2006-01-24 RU RU2007132701/04A patent/RU2368617C2/ru not_active IP Right Cessation
- 2006-01-24 SI SI200632318T patent/SI2662380T1/sl unknown
- 2006-01-24 US US11/338,468 patent/US7714158B2/en active Active
- 2006-01-24 JP JP2007553502A patent/JP5828608B2/ja active Active
- 2006-01-24 WO PCT/EP2006/000580 patent/WO2006081963A1/en not_active Ceased
- 2006-01-24 EP EP06706375.0A patent/EP1848728B1/en not_active Revoked
- 2006-01-24 LT LTEP13161008.1T patent/LT2662380T/lt unknown
- 2006-01-24 ES ES13161008T patent/ES2712644T3/es active Active
- 2006-01-27 TW TW095103582A patent/TWI374889B/zh not_active IP Right Cessation
- 2006-01-30 AR ARP060100335A patent/AR053012A1/es not_active Application Discontinuation
2007
- 2007-07-12 IL IL184562A patent/IL184562A/en not_active IP Right Cessation
- 2007-07-18 NO NO20073723A patent/NO20073723L/no not_active Application Discontinuation
- 2007-07-25 ZA ZA200706168A patent/ZA200706168B/xx unknown
2015
- 2015-06-30 JP JP2015131571A patent/JP6039754B2/ja active Active
2019
- 2019-02-21 CY CY20191100222T patent/CY1121703T1/el unknown

Also Published As

Publication number	Publication date
AU2006210009B2 (en)	2009-08-13
IL184562A0 (en)	2007-10-31
EP1848728A1 (en)	2007-10-31
JP5828608B2 (ja)	2015-12-09
US20060172975A1 (en)	2006-08-03
HUE042316T2 (hu)	2019-06-28
WO2006081963A1 (en)	2006-08-10
JP6039754B2 (ja)	2016-12-07
ZA200706168B (en)	2008-09-25
MX2007009107A (es)	2007-09-11
JP2008529980A (ja)	2008-08-07
AR053012A1 (es)	2007-04-18
TR201902609T4 (tr)	2019-03-21
IL184562A (en)	2015-11-30
CA2594802C (en)	2012-11-27
ES2478302T3 (es)	2014-07-21
SI2662380T1 (sl)	2019-04-30
KR20070100394A (ko)	2007-10-10
US7714158B2 (en)	2010-05-11
EP2662380B1 (en)	2018-11-21
EP1848728B1 (en)	2014-06-11
AU2006210009A1 (en)	2006-08-10
PT2662380T (pt)	2019-02-27
TWI374889B (en)	2012-10-21
RU2368617C2 (ru)	2009-09-27
CA2594802A1 (en)	2006-08-10
CN101111504A (zh)	2008-01-23
CN101111504B (zh)	2011-12-21
NO20073723L (no)	2007-08-28
TW200638939A (en)	2006-11-16
BRPI0607092A2 (pt)	2009-08-04
EP2662380A1 (en)	2013-11-13
CY1121703T1 (el)	2020-07-31
PL2662380T3 (pl)	2019-05-31
ES2712644T3 (es)	2019-05-14
JP2015205907A (ja)	2015-11-19
DK2662380T3 (en)	2019-03-18
RU2007132701A (ru)	2009-03-10
KR100908529B1 (ko)	2009-07-20

Publication	Publication Date	Title
GB0610680D0 (en)	2006-07-12	Therapeutic compounds
IL193678A0 (en)	2009-05-04	Therapeutic compounds
ZA200900004B (en)	2009-12-30	Therapeutic compounds
IL184562A0 (en)	2007-10-31	Ibandronate polymorph a
IL184720A0 (en)	2007-12-03	Ibandronate polymorph b
GB0603041D0 (en)	2006-03-29	Therapeutic compounds
GB0504995D0 (en)	2005-04-20	Use of a compound
GB0606663D0 (en)	2006-05-10	Therapeutic compounds
IL199697A0 (en)	2010-04-15	Therapeutical uses of eslicarbazepine
EP1968603A4 (en)	2013-01-16	THERAPEUTIC AMINARYLSULFONAMIDE CONJUGATE COMPOUNDS
GB0615809D0 (en)	2006-09-20	Therapeutic compounds
GB0612971D0 (en)	2006-08-09	Therapeutic compounds
GB0625349D0 (en)	2007-01-31	Therapeutic compounds
GB0603455D0 (en)	2006-04-05	Therapeutic compounds
GB0625345D0 (en)	2007-01-31	Therapeutic compounds
EP2114474A4 (en)	2013-07-31	MEDICAL PREPARATION
GB0605573D0 (en)	2006-04-26	Therapeutic Compounds
GB0608269D0 (en)	2006-06-07	Therapeutic compounds
GB2439923B (en)	2011-04-06	Therapeutic compounds
GB0614082D0 (en)	2006-08-23	Therapeutic compounds
GB0619687D0 (en)	2006-11-15	Therapeutic compounds
GB0615907D0 (en)	2006-09-27	Therapeutic Compounds
GB0611498D0 (en)	2006-07-19	Therapeutic compounds
GB0604049D0 (en)	2006-04-12	Therapeutic compounds
GB0610670D0 (en)	2006-07-12	Therapeutic compounds